Cargando…
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Over half of breast-cancer-related deaths are due to recurrence 5 or more years after initial diagnosis and treatment. This latency suggests that a population of residual tumor cells can survive treatment and persist in a dormant state for many years. The role of the microenvironment in regulating t...
Autores principales: | Walens, Andrea, DiMarco, Ashley V, Lupo, Ryan, Kroger, Benjamin R, Damrauer, Jeffrey S, Alvarez, James V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478432/ https://www.ncbi.nlm.nih.gov/pubmed/30990165 http://dx.doi.org/10.7554/eLife.43653 |
Ejemplares similares
-
Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence
por: Walens, Andrea, et al.
Publicado: (2020) -
p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma
por: Li, Zhi‐Qin, et al.
Publicado: (2019) -
Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21
por: Unver, Nese
Publicado: (2021) -
CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016) -
CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy
por: Cherry, Jonathan D., et al.
Publicado: (2020)